BioSpace News Archive

Australian clinical-stage drug development company, Noxopharm, is pleased to report the publication of the latest survival data from the LuPIN study ahead of their formal presentation to the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (February 11-13, 2021)

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the third quarter and first nine months of fiscal year 2021, ended December 31, 2020.

In recognition of World Congenital Heart Defects Awareness week, HD Medical Inc. announces it has screened over 50,000 children for CHDs using HD Steth™.

Novamind Inc., a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has made a strategic investment of AU$827,486, in Bionomics Limited, a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders.

IQVIA™ (NYSE:IQV) today announced that 140 life science companies in nearly 90 countries have selected Orchestrated Customer Engagement (OCE) as their customer engagement solution.

Microbix Biosystems Inc., a life sciences innovator and exporter, reports results for the first quarter of its fiscal 2021, the three-months ended December 31, 2020, with record sales and continued progress upon its strategic goals.

Acer Therapeutics Inc., a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, announced topline results from its bioequivalence trial in which ACER-001 showed similar relative bioavailability compared to BUPHENYL® under fed conditions.

OrthoPediatrics Corp. announced that Dave Bailey, President, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Chief Executive Officer, are scheduled to participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18, 2021.

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the Company will release its fourth quarter and full year 2020 earnings results on Thursday, February 25, 2021, after the close of the market.

Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full year 2020 financial results will be released on Thursday, February 25, 2021, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview To listen to the